Grantham, Mayo, Van Otterloo & Co (GMO)’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.9M | Buy |
2,601,575
+460,904
| +22% | +$17.7M | 0.3% | 38 |
|
|
2025
Q1 | $82.9M | Sell |
2,140,671
-2,012,945
| -48% | -$78M | 0.26% | 41 |
|
|
2024
Q4 | $140M | Buy |
4,153,616
+446,568
| +12% | +$15.1M | 0.46% | 32 |
|
|
2024
Q3 | $152M | Buy |
3,707,048
+561,718
| +18% | +$23M | 0.48% | 33 |
|
|
2024
Q2 | $121M | Buy |
3,145,330
+1,636,365
| +108% | +$63M | 0.41% | 39 |
|
|
2024
Q1 | $64.7M | Sell |
1,508,965
-169,984
| -10% | -$7.29M | 0.24% | 60 |
|
|
2023
Q4 | $62.2M | Buy |
1,678,949
+412,505
| +33% | +$15.3M | 0.27% | 60 |
|
|
2023
Q3 | $45.9M | Buy |
1,266,444
+634,070
| +100% | +$23M | 0.22% | 83 |
|
|
2023
Q2 | $22.5M | Buy |
632,374
+473,664
| +298% | +$16.9M | 0.1% | 171 |
|
|
2023
Q1 | $5.65M | Sell |
158,710
-144,700
| -48% | -$5.15M | 0.03% | 306 |
|
|
2022
Q4 | $10.7M | Sell |
303,410
-1,837,510
| -86% | -$64.6M | 0.06% | 226 |
|
|
2022
Q3 | $63M | Buy |
2,140,920
+192,920
| +10% | +$5.68M | 0.36% | 54 |
|
|
2022
Q2 | $84.8M | Buy |
1,948,000
+1,415,300
| +266% | +$61.6M | 0.46% | 45 |
|
|
2022
Q1 | $23.2M | Buy |
532,700
+298,600
| +128% | +$13M | 0.11% | 171 |
|
|
2021
Q4 | $10.3M | Sell |
234,100
-54,800
| -19% | -$2.42M | 0.05% | 252 |
|
|
2021
Q3 | $11M | Sell |
288,900
-304,900
| -51% | -$11.7M | 0.05% | 235 |
|
|
2021
Q2 | $23.6M | Buy |
593,800
+352,200
| +146% | +$14M | 0.12% | 145 |
|
|
2021
Q1 | $8.62M | Buy |
241,600
+202,500
| +518% | +$7.23M | 0.05% | 249 |
|
|
2020
Q4 | $1.44M | Buy |
39,100
+1,400
| +4% | +$51.5K | 0.01% | 502 |
|
|
2020
Q3 | $1.42M | Sell |
37,700
-86,100
| -70% | -$3.24M | 0.01% | 463 |
|
|
2020
Q2 | $5.05M | Sell |
123,800
-336,600
| -73% | -$13.7M | 0.04% | 241 |
|
|
2020
Q1 | $17.4M | Buy |
460,400
+263,900
| +134% | +$10M | 0.15% | 94 |
|
|
2019
Q4 | $9.23M | Sell |
196,500
-576,532
| -75% | -$27.1M | 0.06% | 196 |
|
|
2019
Q3 | $33M | Sell |
773,032
-1,330,400
| -63% | -$56.8M | 0.23% | 69 |
|
|
2019
Q2 | $84.2M | Sell |
2,103,432
-353,700
| -14% | -$14.2M | 0.59% | 42 |
|
|
2019
Q1 | $103M | Sell |
2,457,132
-46,200
| -2% | -$1.93M | 0.74% | 34 |
|
|
2018
Q4 | $95.7M | Buy |
2,503,332
+70,700
| +3% | +$2.7M | 0.76% | 36 |
|
|
2018
Q3 | $97.7M | Buy |
2,432,632
+725,632
| +43% | +$29.1M | 0.66% | 43 |
|
|
2018
Q2 | $68.8M | Buy |
1,707,000
+196,300
| +13% | +$7.91M | 0.49% | 49 |
|
|
2018
Q1 | $59M | Buy |
1,510,700
+446,000
| +42% | +$17.4M | 0.36% | 58 |
|
|
2017
Q4 | $37.8M | Buy |
1,064,700
+236,800
| +29% | +$8.4M | 0.22% | 76 |
|
|
2017
Q3 | $33.6M | Buy |
827,900
+523,100
| +172% | +$21.2M | 0.2% | 87 |
|
|
2017
Q2 | $13.1M | Sell |
304,800
-305,600
| -50% | -$13.2M | 0.07% | 141 |
|
|
2017
Q1 | $25.7M | Sell |
610,400
-1,209,774
| -66% | -$51M | 0.15% | 112 |
|
|
2016
Q4 | $70.1M | Buy |
1,820,174
+256,838
| +16% | +$9.89M | 0.38% | 69 |
|
|
2016
Q3 | $67.4M | Buy |
1,563,336
+1,408,456
| +909% | +$60.7M | 0.32% | 78 |
|
|
2016
Q2 | $6.71M | Buy |
154,880
+74,980
| +94% | +$3.25M | 0.03% | 263 |
|
|
2016
Q1 | $3.24M | Buy |
+79,900
| New | +$3.24M | 0.01% | 335 |
|